<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.15691.009</object-id><label>Table 3.</label><caption><p>Clinical and tumor characteristics of patients in RCT.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15691.009">http://dx.doi.org/10.7554/eLife.15691.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Variables</th><th colspan="2">Patients</th></tr><tr><th valign="top">TILA-TACE</th><th valign="top">cTACE</th></tr></thead><tbody><tr><td valign="top">Patient number</td><td valign="top">10</td><td valign="top">10</td></tr><tr><td valign="top">Median age, years</td><td valign="top">58 (Range 40&#8211;86)</td><td valign="top">53 (43&#8211;81)</td></tr><tr><td valign="top">Gender (M/F)</td><td valign="top">9 /1 (90.0%/10.0%)</td><td valign="top">7 /3 (70.0%/ 30.0%)</td></tr><tr><td valign="top">Aetiology</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">&#8195;HBV</td><td valign="top">9 (90.0%)</td><td valign="top">8 (80.0%)</td></tr><tr><td valign="top">&#8195;HCV</td><td valign="top">0 (0%)</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">&#8195;Non B-non C</td><td valign="top">1 (10.0%)</td><td valign="top">2 (20.0%)</td></tr><tr><td valign="top">Cirrhosis (radiology)</td><td valign="top">10 (100%)</td><td valign="top">10 (100%)</td></tr><tr><td valign="top">Bilirubin, &#956;M</td><td valign="top">17.2 &#177; 10.1</td><td valign="top">16.7 &#177; 7.6</td></tr><tr><td valign="top">Albumin, g/L</td><td valign="top">38.7 &#177; 3.1</td><td valign="top">38.1 &#177; 5.2</td></tr><tr><td valign="top">AST, U/L</td><td valign="top">64.8 &#177; 44.8</td><td valign="top">52.8 &#177; 19.2</td></tr><tr><td valign="top">ALT, U/L</td><td valign="top">60.6 &#177; 48.0</td><td valign="top">41.0 &#177; 29.9</td></tr><tr><td valign="top">AFP, &gt;400&#160;ng/mL</td><td valign="top">3 (30.0%)</td><td valign="top">4 (40.0%)</td></tr><tr><td valign="top">Child-Pugh class, A/B</td><td valign="top">10/0 (100%/0%)</td><td valign="top">10/0 (100%/0%)</td></tr><tr><td valign="top">The size of largest tumor (cm)</td><td valign="top">7.9 (range 5.0&#8211;13.5)</td><td valign="top">7.5 (range 5.0&#8211;13.0)</td></tr><tr><td valign="top">&#8195;Tumor &gt;10 cm</td><td valign="top">3 (30.0%)</td><td valign="top">3&#160;(30.0%)</td></tr><tr><td valign="top">&#8195;Tumor 5~10&#160;cm</td><td valign="top">7 (70.0%)</td><td valign="top">7&#160;(70.0%)</td></tr><tr><td valign="top">Multifocal tumors in 1 lobe</td><td valign="top">3 (30.0%)</td><td valign="top">3 (30.0%)</td></tr><tr><td valign="top">Multifocal tumors in 2 lobes</td><td valign="top">4 (40.0%)</td><td valign="top">2 (20.0%)</td></tr><tr><td valign="top">BCLC stage</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">&#8195;B</td><td valign="top">7 (70.0%)</td><td valign="top">8 (70.0%)</td></tr><tr><td valign="top">&#8195;C</td><td valign="top">3 (30.0%)</td><td valign="top">2 (20.0%)</td></tr><tr><td valign="top">Macrovascular invasion</td><td valign="top">2 (20.0%)</td><td valign="top">1&#160;(10.0%)</td></tr><tr><td valign="top">&#8195;The right branch of portal vein</td><td valign="top">1&#160;(10.0%)</td><td valign="top">1&#160;(10.0%)</td></tr><tr><td valign="top">&#8195;The left branch of portal vein</td><td valign="top">1&#160;(10.0%)</td><td valign="top">0 (0%)</td></tr><tr><td valign="top">Extra-hepatic metastasis</td><td valign="top">1&#160;(10.0%)</td><td valign="top">2&#160;(20.0%)</td></tr><tr><td valign="top">&#8195;Brain</td><td valign="top">0 (0%)</td><td valign="top">1&#160;(10.0%)</td></tr><tr><td valign="top">&#8195;Lymph nodes</td><td valign="top">1&#160;(10.0%)</td><td valign="top">1 (10.0%)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn10"><p>HBV, hepatitis B virius;</p></fn><fn id="tblfn11"><p>HCV, hepatitis C virius;</p></fn><fn id="tblfn12"><p>AST, Aspartate transaminase;</p></fn><fn id="tblfn13"><p>ALT, Alanine aminotransferase;</p></fn><fn id="tblfn14"><p>AFP, alpha-feto-protein.</p></fn></table-wrap-foot></table-wrap>